Keybanc analyst Scott Schoenhaus initiates coverage on Health Catalyst (NASDAQ:HCAT) with a Sector Weight rating.
Rhythm Pharmaceuticals Presents First-ever Data Showing Improvements In Health-related Quality Of Life For Patients Living With Bardet-Biedl Syndrome At ObesityWeek 2021
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, this week presented the first-ever data
